NeuroStar TMS Therapy System: Utilization and Outcomes
- Conditions
- Major Depressive Disorder
- Registration Number
- NCT01114477
- Lead Sponsor
- Neuronetics
- Brief Summary
The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 307
- Major Depressive Disorder
- Contraindications to treatment with TMS
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Score on the Patient Health Questionnaire 9-Item (PHQ-9) Baseline and 6 weeks The primary outcome measure will reported as the change from baseline through 6 weeks for the total score on the PHQ-9.
- Secondary Outcome Measures
Name Time Method Health Resource Utilization Questionnaire (HRU) Baseline, 6 weeks, and 12 Months The change from baseline in health care service utilization reported on the individual questions contained in the HRU will be reported for the 6 week and 12 month time points.
Total score for the Clinical Global Impressions-Severity (CGI-S) Baseline, 6 weeks and 12 Months The change from baseline to endpoint on the total score for the CGI-S will be reported for the 6 week and 12 month time points.
Total Score for the EuroQol Questionnaire (EQ-5D) Baseline, 6 weeks, and 12 Months. The change from baseline to endpoint on the total score for the EQ-5D will be reported for the 6 week and 12 month time points.
Short Form 36-Item Questionnaire(SF-36) Individual Factor Scores and General Medical and Mental Health Composite Scores Baseline, 6 weeks, and 12 Months. The change from baseline to endpoint on the Individual Factor Scores and General Medical and Mental Health Composite Scores for the SF-36 will be reported for the 6 week and 12 month time points.
Total score for the Inventory of Depressive Symptoms-Self Report (IDS-SR) Baseline, 6 weeks and 12 Months The change from baseline to endpoint on the total score for the IDS-SR will be reported for the 6 week and 12 month time points.
Trial Locations
- Locations (44)
Lee Ann Kelley, M.D., PC
🇺🇸Phoenix, Arizona, United States
Sacramento TMS
🇺🇸El Dorado Hills, California, United States
Todd Hutton, MD & Associates
🇺🇸Pasadena, California, United States
Arjun Reyes, MD
🇺🇸Woodland Hills, California, United States
Behavioral Health Care Associates
🇺🇸Schaumburg, Illinois, United States
TMS Center of Beverly Hills
🇺🇸Beverly Hills, California, United States
Curtis Cassidy, MD
🇺🇸Lakeland, Florida, United States
Brain Stimulation Chicago North Shore
🇺🇸Northbrook, Illinois, United States
Butler Hospital
🇺🇸Providence, Rhode Island, United States
The Botkiss Center for TMS Therapy
🇺🇸San Diego, California, United States
Kevin Kinback, MD
🇺🇸Mission Viejo, California, United States
Stanford Hospital and Clinics
🇺🇸Stanford, California, United States
Christiana Care Health Services
🇺🇸Wilmington, Delaware, United States
Santa Fe TMS Therapy Center
🇺🇸Santa Fe, New Mexico, United States
Central Psychiatry
🇺🇸Las Vegas, Nevada, United States
Dent Neurosciences Research Center, Inc.
🇺🇸Amherst, New York, United States
Anthony Drobnick, MD
🇺🇸St. Michaels, Maryland, United States
Spectrum Behavioral Health
🇺🇸Annapolis, Maryland, United States
Health Sciences America, LLC
🇺🇸Boca Raton, Florida, United States
Brian Teliho, MD
🇺🇸Atlanta, Georgia, United States
Serenity Center for Depression, P.A.
🇺🇸Sugar Land, Texas, United States
Orange County TMS Center
🇺🇸Laguna Hills, California, United States
Hartford Hospital
🇺🇸Hartford, Connecticut, United States
Rush University Medical Center
🇺🇸Chicago, Illinois, United States
Carl M. Wahlstrom, Jr. MD Limited
🇺🇸Chicago, Illinois, United States
Sheppard Pratt Health System
🇺🇸Baltimore, Maryland, United States
Bay Psychiatric Associates
🇺🇸Berkeley, California, United States
Clinical Training & Research Institute
🇺🇸Burlingame, California, United States
Martha Koo, MD
🇺🇸Hermosa Beach, California, United States
Comprehensive Psychiatric Care
🇺🇸Norwich, Connecticut, United States
Integrative Psychiatry
🇺🇸Louisville, Kentucky, United States
Newton-Wellesley Psychiatry
🇺🇸Newton, Massachusetts, United States
TMS Center of New England
🇺🇸Portsmouth, New Hampshire, United States
W. Scott West, M.D.
🇺🇸Nashville, Tennessee, United States
Texas TMS Center at Senior Adults Specialty Healthcare (SASH)
🇺🇸Austin, Texas, United States
Houston TMS
🇺🇸Houston, Texas, United States
Depression Research Center and Clinic-Semel Institute for Neuroscience & Human Behavior at UCLA
🇺🇸Los Angeles, California, United States
University Psychiatric Foundation
🇺🇸Louisville, Kentucky, United States
Center for Anxiety and Depression
🇺🇸Mercer Island, Washington, United States
The TMS Institute of Pennsylvania-Advanced Neuropsychiatric Solutions
🇺🇸West Chester, Pennsylvania, United States
Northwestern Medical Faculty Foundation
🇺🇸Chicago, Illinois, United States
Agape Mind Services/The Costello Clinic
🇺🇸Lewisville, Texas, United States
University Neuropsychiatric Institute
🇺🇸Salt Lake City, Utah, United States
Texas Neuropsychiatric Institute
🇺🇸Amarillo, Texas, United States